captopril has been researched along with Carditis in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 8 (47.06) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 3 (17.65) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Wahab, BA; El-khawanki, MM; Hashim, AM; Metwally, ME | 1 |
| Guo, C; Liang, H; Wang, Y; Zhang, J | 1 |
| Chen, Y; Fang, YN; Guo, CY; Li, Q; Wang, Y | 1 |
| Kong, QF; Song, SZ; Xie, XY | 1 |
| Engman, DM; Fornek, JL; Godsel, LM; Leon, JS; Molteni, A; Wang, K | 1 |
| Cao, YD; Chang, J; Chen, JB; Liao, XG; Rao, BF | 1 |
| Bahk, TJ; Daniels, MD; Engman, DM; Leon, JS; Wang, K | 1 |
| Ikäheimo, M; Pirttiaho, H; Takkunen, J | 1 |
| Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T | 1 |
| Fujita, J; Kyu, BS; Matoba, Y; Matsumori, A; Sasayama, S; Suzuki, H; Tanaka, A | 1 |
| Kloner, RA; Raikar, S; Rezkalla, SH | 1 |
| Hiraoka, Y; Kishimoto, C; Kurokawa, M; Sasayama, S; Shiraki, K; Takada, H | 1 |
| Kawai, C | 1 |
| Khatib, G; Khatib, R; Kloner, RA; Rezkalla, S | 2 |
| Kawai, C; Matsumori, A; Suzuki, H | 1 |
| Bühlmeyer, K; Emmrich, P; Genz, T; Stern, H | 1 |
2 review(s) available for captopril and Carditis
| Article | Year |
|---|---|
Treatment of viral myocarditis with focus on captopril.
Topics: Acute Disease; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Humans; Myocarditis | 1996 |
Pharmacotherapy of dilated cardiomyopathy: current status and future directions.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Cardiomyopathy, Dilated; Forecasting; Humans; Male; Mice; Myocarditis | 1992 |
2 trial(s) available for captopril and Carditis
| Article | Year |
|---|---|
[Clinical study on therapeutic effects of treatment according to syndrome differentiation of traditional Chinese medicine combined with captopril on severe viral myocarditis complicated heart failure].
Topics: Adult; Captopril; Diagnosis, Differential; Drugs, Chinese Herbal; Female; Heart Failure; Humans; Male; Medicine, Chinese Traditional; Myocarditis; Phytotherapy | 2001 |
Pharmacotherapy of dilated cardiomyopathy: current status and future directions.
Topics: Adrenergic beta-Antagonists; Animals; Captopril; Cardiomyopathy, Dilated; Forecasting; Humans; Male; Mice; Myocarditis | 1992 |
14 other study(ies) available for captopril and Carditis
| Article | Year |
|---|---|
Protective effect of captopril against clozapine-induced myocarditis in rats: role of oxidative stress, proinflammatory cytokines and DNA damage.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antipsychotic Agents; Captopril; Clozapine; Cytokines; Deoxyguanosine; DNA Damage; Gene Expression Regulation; Male; Myocarditis; Oxidative Stress; Rats; Rats, Wistar | 2014 |
ADAMTS-1 contributes to the antifibrotic effect of captopril by accelerating the degradation of type I collagen in chronic viral myocarditis.
Topics: ADAM Proteins; ADAMTS1 Protein; Animals; Blotting, Western; Captopril; Chronic Disease; Collagen Type I; Coloring Agents; Fibrinolysis; Fibrosis; Kinetics; Male; Mice; Mice, Inbred BALB C; Myocarditis; Peptide Fragments; Peptides; Procollagen; Reverse Transcriptase Polymerase Chain Reaction; Staining and Labeling | 2010 |
[Antifibrotic effects of oxymatrine in mice with chronic viral myocarditis].
Topics: Alkaloids; Animals; Antiviral Agents; Captopril; Chronic Disease; Disease Models, Animal; Down-Regulation; Enterovirus B, Human; Fibrosis; Male; Mice; Mice, Inbred BALB C; Myocarditis; Myocardium; Quinolizines; Transforming Growth Factor beta1; Virus Diseases | 2010 |
Captopril prevents experimental autoimmune myocarditis.
Topics: Administration, Oral; Animals; Autoantibodies; Autoantigens; Autoimmune Diseases; Captopril; Cardiomegaly; Cell Division; Cells, Cultured; Cytokines; Epitopes, T-Lymphocyte; Hypersensitivity, Delayed; Injections, Subcutaneous; Male; Mice; Mice, Inbred A; Mice, Inbred BALB C; Mice, Transgenic; Myocarditis; Myosins; Ovalbumin; Peptidyl-Dipeptidase A; T-Lymphocyte Subsets; Up-Regulation | 2003 |
[Effects of captopril on myocardial energy metabolism in mice with viral myocarditis].
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Coxsackievirus Infections; Energy Metabolism; Male; Mice; Mice, Inbred BALB C; Mitochondria; Myocarditis; Myocardium; Random Allocation; Succinate Dehydrogenase | 2003 |
Comparison of angiotensin converting enzyme inhibition and angiotensin II receptor blockade for the prevention of experimental autoimmune myocarditis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Autoantibodies; Autoimmunity; Captopril; Fibrosis; Losartan; Male; Mice; Myocarditis; Myosins | 2008 |
[Captopril therapy of severe heart failure after carditis].
Topics: Adult; Captopril; Heart Failure; Humans; Male; Myocarditis; Proline | 1982 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Captopril; Cardiovirus Infections; Enalapril; Encephalomyocarditis virus; Female; Heart; Heart Failure; Hypertrophy, Left Ventricular; Imidazoles; Injections, Intraperitoneal; Losartan; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; Organ Size; Random Allocation; Tetrazoles; Therapeutic Equivalency | 1995 |
Enhanced expression of superoxide dismutase messenger RNA in viral myocarditis. An SH-dependent reduction of its expression and myocardial injury.
Topics: Animals; Base Sequence; Body Weight; Captopril; Encephalomyocarditis virus; Enterovirus Infections; Free Radicals; Heart; Mice; Mice, Inbred BALB C; Molecular Sequence Data; Myocarditis; Myocardium; Organ Size; Oxygen; RNA, Messenger; Superoxide Dismutase; Survival Analysis; Tiopronin | 1993 |
Captopril suppresses interstitial fibrin deposition in coxsackievirus B3 myocarditis.
Topics: Animals; Captopril; Chlorocebus aethiops; Connective Tissue; Coxsackievirus Infections; Enterovirus B, Human; Extracellular Space; Fibrin; Myocarditis; Myocardium; Myosins; Organ Size | 1997 |
Beneficial effects of captopril in acute coxsackievirus B3 murine myocarditis.
Topics: Animals; Captopril; Coxsackievirus Infections; Enterovirus B, Human; Mice; Myocarditis; Myocardium; Organ Size; Time Factors | 1990 |
Beneficial effects of captopril in coxsackievirus myocarditis.
Topics: Animals; Captopril; Coxsackievirus Infections; Enterovirus B, Human; Mice; Myocarditis | 1990 |
Effect of delayed captopril therapy on left ventricular mass and myonecrosis during acute coxsackievirus murine myocarditis.
Topics: Acute Disease; Animals; Calcinosis; Captopril; Coxsackievirus Infections; Drug Evaluation, Preclinical; Enterovirus B, Human; Heart; Heart Ventricles; Lung; Mice; Myocarditis; Myocardium; Necrosis; Organ Size; Time Factors | 1990 |
[Hemodynamic effect of captopril in children with dilated cardiomyopathy].
Topics: Adolescent; Captopril; Cardiomyopathy, Dilated; Child; Child, Preschool; Drug Therapy, Combination; Echocardiography, Doppler; Follow-Up Studies; Hemodynamics; Humans; Infant; Infant, Newborn; Myocarditis; Prospective Studies | 1988 |